Expression of p43 associated placental isoferritin (PLF) correlates inversely with cell growth in breast cancer cells lines MCF-7 and T47-D
- 1. Cancer Research Institute, Slovak Academy of Sciences, 81232 Bratislava (Slovak Republic)
- 2. Department of Surgery, Hanusch Medical Center, University of Vienna, Donauspitalin SMZ-Ost, Vienna (Austria)
Description
We have previously demonstrated that the expression of the recently described immunosuppressive antigen p43 in breast cancer patients correlates with early stages of the disease and a low degree of proliferation of the tumor. Attempts were made to evaluate the expression of p43 in two breast cancer cell lines (MCF-7 and T47-D) stimulated to proliferation by 17-beta estradiol and fetal bovine serum (FBS). p43 expression was determined by RIA technique using the new monoclonal antibody CM-H-9, the rate of proliferation was was assessed by [3H]thymidine incorporation during 72 hours of incubation. Induction of proliferation by addition of 17-beta-estradiol and FBS to serum-free tissue culture medium correlated with a decrease of p43 synthesis of both cell lines. The level of p43 expression in non-stimulated cells was low in comparison to that in cells cultivated routinely (15% FBS, no estrogen). However, the drop of p43 was significantly stronger in cell lines with estrogen stimulated proliferation. Our in vitro results confirmed previous clinical observations describing an inverse correlation between p43 synthesis and degree of proliferation and differentiation in breast cancer for the first time. However, the pathologic mechanisms leading to this phenomenon need to be elucidated. (author)
Additional details
Publishing Information
- Journal Title
- Neoplasma
- Journal Volume
- 40
- Journal Issue
- 3
- Journal Page Range
- p. 147-151
- ISSN
- 0028-2685
INIS
- Country of Publication
- Slovakia
- Country of Input or Organization
- Slovakia
- INIS RN
- 29060751
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Resource subtype / Literary indicator
- Numerical Data
- Descriptors DEI
- ANTIGENS; CELL DIFFERENTIATION; CELL PROLIFERATION; DIAGNOSIS; ESTRADIOL; EXPERIMENTAL DATA; FERRITIN; IODINATION; IODINE 125; LABELLED COMPOUNDS; LABELLING; MAMMARY GLANDS; NEOPLASMS; NUCLEAR MEDICINE; RADIOIMMUNOASSAY; RADIONUCLIDE KINETICS; THYMIDINE; TRACER TECHNIQUES; TRITIUM; UPTAKE
- Descriptors DEC
- AZINES; BETA DECAY RADIOISOTOPES; BETA-MINUS DECAY RADIOISOTOPES; BODY; CHEMICAL REACTIONS; COMPLEXES; DATA; DAYS LIVING RADIOISOTOPES; DISEASES; ELECTRON CAPTURE RADIOISOTOPES; ESTRANES; ESTROGENS; GLANDS; HALOGENATION; HETEROCYCLIC COMPOUNDS; HORMONES; HYDROGEN ISOTOPES; HYDROXY COMPOUNDS; IMMUNOASSAY; INFORMATION; INTERMEDIATE MASS NUCLEI; INTERNAL CONVERSION RADIOISOTOPES; IODINE ISOTOPES; IRON COMPLEXES; ISOTOPE APPLICATIONS; ISOTOPES; KINETICS; LIGHT NUCLEI; MEDICINE; METALLOPROTEINS; NUCLEI; NUCLEOSIDES; NUCLEOTIDES; NUMERICAL DATA; ODD-EVEN NUCLEI; ORGANIC COMPOUNDS; ORGANIC NITROGEN COMPOUNDS; ORGANS; PROTEINS; PYRIMIDINES; RADIOASSAY; RADIOISOTOPES; RIBOSIDES; STEROID HORMONES; STEROIDS; TRACER TECHNIQUES; TRANSITION ELEMENT COMPLEXES; YEARS LIVING RADIOISOTOPES
Optional Information
- Notes
- 2 figs., 24 refs.